Tern Plc announces 63% take-up of Open Offer

TERN

Tern Plc (LON:TERN), the Company focused on value creation from Internet of Things technology businesses, has announced the results of its Open Offer to Qualifying Shareholders which was announced on 21 April 2026 and closed for acceptances, in accordance with its terms, on 7 May 2026.

The Company announces that valid acceptances have been received from Qualifying Shareholders for a total of 67,666,314 new Ordinary Shares under the Open Offer, representing a take-up of approximately 63% of the 107,268,195 Open Offer Shares available.

The Open Offer is conditional upon the passing of the Resolutions at a General Meeting being held at 11.00 a.m. today, 8 May 2026, and Admission of the Open Offer Shares to trading on AIM. Subject to the passing of the Resolutions, the Open Offer will raise gross proceeds of approximately £406,000 for the Company and it is expected that Admission will become effective and dealings in the Open Offer Shares on AIM will commence on 11 May 2026.

A further announcement will be made following the conclusion of the General Meeting.

Capitalised terms used but not otherwise defined in this announcement bear the meanings ascribed to them in the circular posted to shareholders on 21 April 2026.

Director and PDMR participation in the Open Offer

The following Director and persons discharging managerial responsibilities (“PDMRs“) of the Company have opted to participate in the Open Offer, and conditional upon the passing of the Resolutions at the General Meeting and Admission will subscribe for the Open Offer Shares as follows:

DirectorNumber of Existing Ordinary SharesNumber of Open Offer Shares subscribed forNumber of Ordinary Shares to be held on Admission% of the Enlarged Share Capital to be held on Admission
Iain Ross1,843,808263,4012,107,2090.26%
PDMRNumber of Existing Ordinary SharesNumber of Open Offer Shares subscribed forNumber of Ordinary Shares to be held on Admission% of the Enlarged Share Capital to be held on Admission
Albert Sisto21,126,0961,500,39422,626,4902.76%

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Search